Live feed
Filing
SC 13D/A
SC 13D/A0001144204-17-065336·CELGENE CORP /DE/
Schedule 13D ownership disclosure
CRISPR Therapeutics AG
Security class unavailable · CUSIP: H17182108
Event date: 2017-12-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-17-065336
- Form type
- SC 13D/A
- Filer
- CELGENE CORP /DE/
- CIK
- CIK 816284
- Filed
- Dec 26, 2017
- Reporting period
- Dec 22, 2017
- Description
- Schedule 13D beneficial ownership